BIOLASE (NASDAQ:BIOL) released its quarterly earnings results on Wednesday. The medical technology company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04), Bloomberg Earnings reports. BIOLASE had a negative net margin of 36.28% and a negative return on equity of 74.51%.
Shares of BIOLASE (NASDAQ BIOL) opened at $0.46 on Thursday. BIOLASE has a 1 year low of $0.28 and a 1 year high of $1.45.
BIOLASE Company Profile
BIOLASE, Inc (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers.
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.